tirzepatide injection price Mounjaro 5 Mg ₹4500 per Boxes in Mumbai India Newer Weight-Loss Drugs Not Cost-effective

What It Does Tirzepatide works on **two hormones** (GLP-1 and GIP) to help control appetite, fullness, and blood sugar

Benefits patients commonly report Reduced appetite and food noise Steadier, more sustainable weight management when paired with diet and lifestyle changes Improved insulin sensitivity and blood sugar regulation More predictable daytime energy Less reactive eating and fewer cravings A note on whole body wellness Many patients describe broader lifestyle wins as their habits steady, including better sleep, more consistent meals, and a clearer sense of routine

Chicken breast, turkey, and fish contain less sulfur per gram than red meat

Key Points The incretins glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gut-derived hormones that potentiate insulin secretion and contribute to glucose metabolism through a wide range of physiological actions Inhibitors of the incretin-inactivating enzyme dipeptidyl peptidase 4 (DPP-4) and DPP-4-resistant injectable GLP-1 receptor agonists have been developed for the treatment of hyperglycaemia in type 2 diabetes mellitus (T2DM) GLP-1 and other gut-derived hormones might directly and/or indirectly regulate electrolyte and fluid homeostasis by influencing feeding and drinking behaviour as well as electrolyte transport in the kidneys and gastrointestinal tract GLP-1 receptor (GLP-1R) agonists and DPP-4 inhibitors increase natriuresis in T2DM, possibly through overlapping and distinct mechanisms, and might slightly improve renal haemodynamics in the setting of diabetes-related glomerular hyperfiltration Incretin-based therapies seem to directly influence renal physiology and have indirect metabolic and haemodynamic actions that might reduce renal risk in T2DM